RPT | Novo Nordisk To Present Clinical Data On Wegovy Pill At EASD 2026
New Semaglutide Data To Cover Obesity, Diabetes, Cardiovascular, Kidney, Liver Disease
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results.
Novo Nordisk To present Clinical Data On Wegovy Pill
New Semaglutide Data To Cover Obesity, Diabetes, Cardiovascular, Kidney, Liver Disease
Zealand Pharma Rethinks Obesity Strategy
Recent setbacks for Danish biotech Zealand Pharma forced analysts to rethink the company's obesity strategy While its drug survodutide disappointed in terms of dropout rates, analysts remain upbeat on its amylin-based drug petrelintide An emerging theme in the weight loss space is the growing acknowledgement of the nee
Zealand Pharma Tumbles
Recent setbacks for Danish biotech Zealand Pharma forced analysts to rethink the company's obesity strategy While its drug survodutide disappointed in terms of dropout rates, analysts remain upbeat on its amylin-based drug petrelintide An emerging theme in the weight loss space is the growing acknowledgement of the nee